To assess the potential of BM-derived CD11b+GR-1+ IMCs to limit T-cell activation and proliferation, we purified IMCs from BM of tumor-free mice that had a phenotype comparable to that of MDSC from tumor-bearing mice. Here, ITGAM is linked to neoplasm.